Lutathera (Lu-177 dotatate)

Lutathera (Lu-177 dotatate) is a targeted radioactive therapy used to treat certain types of neuroendocrine tumors, which are rare cancers originating from hormone-producing cells. It combines a radioactive element, Lutetium-177, with a molecule that specifically binds to tumor cells expressing somatostatin receptors. Once attached, it delivers localized radiation to kill the cancer cells while minimizing damage to surrounding healthy tissue. This treatment is often used when tumors can't be removed surgically or have spread, providing a targeted approach to control tumor growth and improve quality of life.